Kexing Biopharm | WebDisclosure

BRIEF

published on 10/10/2026 at 16:40, 3 hours 8 minutes ago

Kexing Biopharm Expands Global Presence at CPHI Milan 2026

Global Expansion Pharmaceuticals Biosimilars CPHI Milan Kexing Biopharm
BRIEF

published on 10/10/2026 at 16:40, 3 hours 8 minutes ago

Kexing Biopharm renforce sa présence mondiale au CPHI Milan 2026

Expansion Mondiale Médicaments Biosimilaires CPHI Milan Kexing Biopharm
PRESS RELEASE

published on 10/10/2026 at 16:35, 3 hours 13 minutes ago

New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
Kexing Biopharm showcased its global innovative drug pipeline and expansion plans at CPHI Milan 2026, aiming for global cooperation and market presence

Expansion Global Cooperation CPHI Milan Kexing Biopharm Innovative Drug Pipeline
BRIEF

published on 06/24/2026 at 06:00, 3 months 16 days ago

Kexing Biopharm Wraps Up Successful CPHI & PMEC China 2026 Participation

Global Expansion International Markets R&D Innovation Pharmaceutical Exhibition Drug Pipelines
BRIEF

published on 06/24/2026 at 06:00, 3 months 16 days ago

Kexing Biopharm conclut avec succès sa participation aux conférences CPHI et PMEC China 2026.

Expansion Mondiale Marchés Internationaux Innovation En R&D Salon Pharmaceutique Pipelines De Médicaments
PRESS RELEASE

published on 06/24/2026 at 05:55, 3 months 16 days ago

Beyond Horizons, Forward Together | Kexing Biopharm Concludes Participation in CPHI & PMEC China 2026
Kexing Biopharm showcased innovative drug pipelines at CPHI & PMEC China 2026, receiving R&D Innovation Award. Company deepening global presence for high-quality products

Kexing Biopharm CPHI & PMEC China 2026 Innovative Drug Pipelines R&D Innovation Award Global Pharmaceutical Market
BRIEF

published on 06/04/2026 at 13:20, 4 months 6 days ago

Kexing Biopharm Advances GB10 in Phase I Clinical Trial in China

Phase I Trial Patient Compliance Ophthalmic Drug GB10 NAMD Treatment
BRIEF

published on 06/04/2026 at 13:20, 4 months 6 days ago

Kexing Biopharm fait progresser le GB10 dans un essai clinique de phase I en Chine

Essai De Phase I GB10 Médicament Ophtalmique Traitement De La DMLA Néovasculaire Respect Des Consignes Du Patient
PRESS RELEASE

published on 06/04/2026 at 13:15, 4 months 6 days ago

Innovative Drug Update | Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10
Kexing Biopharm enrolls first subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10, marking a significant milestone in innovative drug R&D pipeline

Phase I Clinical Trial Neovascular Age-Related Macular Degeneration Kexing Biopharm GB10 Ophthalmic Innovative Drug
BRIEF

published on 10/31/2025 at 12:30, 11 months 10 days ago

Kexing Biopharm Explores Global Expansion at CPHI Frankfurt 2025

Biopharmaceutical Innovation Global Strategy Pharmaceutical Expansion Kexing Biopharm CPHI Frankfurt

Published on 10/10/2026 at 04:45, 15 hours 3 minutes ago

Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 17 hours 45 minutes ago

BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 17 hours 48 minutes ago

Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 20 hours 48 minutes ago

Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 21 hours 33 minutes ago

Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call

View all ACCESSWIRE

Published on 10/10/2026 at 16:35, 3 hours 13 minutes ago

New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
Published on 10/10/2026 at 16:30, 3 hours 18 minutes ago

ZPMC-Built Infrastructure Supports China's First Offshore Wind Project to Deploy 18 MW Turbines at Scale
Published on 10/10/2026 at 10:05, 9 hours 43 minutes ago

ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
Published on 10/09/2026 at 21:24, 22 hours 23 minutes ago

Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Published on 10/09/2026 at 21:17, 22 hours 30 minutes ago

EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected

View all EQS

Published on 10/09/2026 at 19:27, 1 day ago

Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/09/2026 at 19:27, 1 day ago

Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Published on 10/09/2026 at 18:01, 1 day 1 hour ago

Titre de mon communiqué
Published on 10/09/2026 at 18:01, 1 day 1 hour ago

Title of my press release
Published on 10/09/2026 at 17:45, 1 day 2 hours ago

Déclaration des droits de vote à fin septembre 2026

View all LES ECHOS COMFI WIRE

News